Studies have shown tumor-induced functional deficiency of DC in breast cancer patients and reduced antigen-presenting functions in expanded Lin−HLA-DR+ cells in peripheral blood of cancer patients [35]. This evidence concerns the gene DCX and breast carcinoma.